The biliary excretion of biotin and biotin metabolites is a quantitatively minor route of excretion in rats

J. Zempleni, G. M. Green, A. U. Spannagel, D. M. Mock

Research output: Contribution to journalArticle

Abstract

We sought to determine whether the biliary excretion of biotin and biotin metabolites contributes importantly to the overall excretion of the vitamin in mammals, and hence, whether metabolism by gut microorganisms could account for some metabolism of biotin. [14C]Carbonyl-labeled biotin (158 pmol/g body weight) was injected i.v. into six rats; bile and urine were collected in timed intervals for 24 h after injection. Biotin, bisnorbiotin (BNB), biotin-d,l-sulfoxide (BSO), bisnorbiotin methyl ketone (BNBMK), and two unidentified compounds (designated A and B) were quantitated in bile and urine using HPLC/radiometric flow detection. For these six compounds totaled, 1.9 ± 0.2% of the administered 14C was found in bile and 60.6 ± 4.1% in urine. Biotin per se accounted for ∼one-half of the excretion in bile and urine. In bile, BNBMK (11% of total biliary 14C), the unknown compound A (9%), and compound B (25%) were quantitatively the most abundant metabolites. In urine, BNB (24% of total urinary 14C) and BSO (14%) were the most abundant metabolites. The biliary excretion of biotin and metabolites decreased rapidly; 6 h after biotin injection, 14C was not detectable in bile any more. The urinary excretion of BNB, BNBMK, and compounds A and B, however, remained on a constant level during the first 6 h after biotin administration and decreased thereafter. These data provide evidence that the biliary excretion of biotin and metabolites is a quantitatively negligible route of excretion, and we conclude that enteric metabolism of parenteral biotin is unlikely.

Original languageEnglish (US)
Pages (from-to)A233
JournalFASEB Journal
Volume11
Issue number3
StatePublished - Dec 1 1997

Fingerprint

biotin
Biotin
Metabolites
Rats
excretion
metabolites
rats
bile
Bile
sulfoxide
urine
Urine
ketones
Metabolism
Hepatobiliary Elimination
metabolism
injection
Injections
Mammals
Vitamins

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

The biliary excretion of biotin and biotin metabolites is a quantitatively minor route of excretion in rats. / Zempleni, J.; Green, G. M.; Spannagel, A. U.; Mock, D. M.

In: FASEB Journal, Vol. 11, No. 3, 01.12.1997, p. A233.

Research output: Contribution to journalArticle

Zempleni, J. ; Green, G. M. ; Spannagel, A. U. ; Mock, D. M. / The biliary excretion of biotin and biotin metabolites is a quantitatively minor route of excretion in rats. In: FASEB Journal. 1997 ; Vol. 11, No. 3. pp. A233.
@article{b2708e490ac14ceaa1d46a8928cf2568,
title = "The biliary excretion of biotin and biotin metabolites is a quantitatively minor route of excretion in rats",
abstract = "We sought to determine whether the biliary excretion of biotin and biotin metabolites contributes importantly to the overall excretion of the vitamin in mammals, and hence, whether metabolism by gut microorganisms could account for some metabolism of biotin. [14C]Carbonyl-labeled biotin (158 pmol/g body weight) was injected i.v. into six rats; bile and urine were collected in timed intervals for 24 h after injection. Biotin, bisnorbiotin (BNB), biotin-d,l-sulfoxide (BSO), bisnorbiotin methyl ketone (BNBMK), and two unidentified compounds (designated A and B) were quantitated in bile and urine using HPLC/radiometric flow detection. For these six compounds totaled, 1.9 ± 0.2{\%} of the administered 14C was found in bile and 60.6 ± 4.1{\%} in urine. Biotin per se accounted for ∼one-half of the excretion in bile and urine. In bile, BNBMK (11{\%} of total biliary 14C), the unknown compound A (9{\%}), and compound B (25{\%}) were quantitatively the most abundant metabolites. In urine, BNB (24{\%} of total urinary 14C) and BSO (14{\%}) were the most abundant metabolites. The biliary excretion of biotin and metabolites decreased rapidly; 6 h after biotin injection, 14C was not detectable in bile any more. The urinary excretion of BNB, BNBMK, and compounds A and B, however, remained on a constant level during the first 6 h after biotin administration and decreased thereafter. These data provide evidence that the biliary excretion of biotin and metabolites is a quantitatively negligible route of excretion, and we conclude that enteric metabolism of parenteral biotin is unlikely.",
author = "J. Zempleni and Green, {G. M.} and Spannagel, {A. U.} and Mock, {D. M.}",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "11",
pages = "A233",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - The biliary excretion of biotin and biotin metabolites is a quantitatively minor route of excretion in rats

AU - Zempleni, J.

AU - Green, G. M.

AU - Spannagel, A. U.

AU - Mock, D. M.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - We sought to determine whether the biliary excretion of biotin and biotin metabolites contributes importantly to the overall excretion of the vitamin in mammals, and hence, whether metabolism by gut microorganisms could account for some metabolism of biotin. [14C]Carbonyl-labeled biotin (158 pmol/g body weight) was injected i.v. into six rats; bile and urine were collected in timed intervals for 24 h after injection. Biotin, bisnorbiotin (BNB), biotin-d,l-sulfoxide (BSO), bisnorbiotin methyl ketone (BNBMK), and two unidentified compounds (designated A and B) were quantitated in bile and urine using HPLC/radiometric flow detection. For these six compounds totaled, 1.9 ± 0.2% of the administered 14C was found in bile and 60.6 ± 4.1% in urine. Biotin per se accounted for ∼one-half of the excretion in bile and urine. In bile, BNBMK (11% of total biliary 14C), the unknown compound A (9%), and compound B (25%) were quantitatively the most abundant metabolites. In urine, BNB (24% of total urinary 14C) and BSO (14%) were the most abundant metabolites. The biliary excretion of biotin and metabolites decreased rapidly; 6 h after biotin injection, 14C was not detectable in bile any more. The urinary excretion of BNB, BNBMK, and compounds A and B, however, remained on a constant level during the first 6 h after biotin administration and decreased thereafter. These data provide evidence that the biliary excretion of biotin and metabolites is a quantitatively negligible route of excretion, and we conclude that enteric metabolism of parenteral biotin is unlikely.

AB - We sought to determine whether the biliary excretion of biotin and biotin metabolites contributes importantly to the overall excretion of the vitamin in mammals, and hence, whether metabolism by gut microorganisms could account for some metabolism of biotin. [14C]Carbonyl-labeled biotin (158 pmol/g body weight) was injected i.v. into six rats; bile and urine were collected in timed intervals for 24 h after injection. Biotin, bisnorbiotin (BNB), biotin-d,l-sulfoxide (BSO), bisnorbiotin methyl ketone (BNBMK), and two unidentified compounds (designated A and B) were quantitated in bile and urine using HPLC/radiometric flow detection. For these six compounds totaled, 1.9 ± 0.2% of the administered 14C was found in bile and 60.6 ± 4.1% in urine. Biotin per se accounted for ∼one-half of the excretion in bile and urine. In bile, BNBMK (11% of total biliary 14C), the unknown compound A (9%), and compound B (25%) were quantitatively the most abundant metabolites. In urine, BNB (24% of total urinary 14C) and BSO (14%) were the most abundant metabolites. The biliary excretion of biotin and metabolites decreased rapidly; 6 h after biotin injection, 14C was not detectable in bile any more. The urinary excretion of BNB, BNBMK, and compounds A and B, however, remained on a constant level during the first 6 h after biotin administration and decreased thereafter. These data provide evidence that the biliary excretion of biotin and metabolites is a quantitatively negligible route of excretion, and we conclude that enteric metabolism of parenteral biotin is unlikely.

UR - http://www.scopus.com/inward/record.url?scp=33750157674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750157674&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750157674

VL - 11

SP - A233

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -